Compare Dr. Reddys with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ABBOTT INDIA - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB ABBOTT INDIA DR. REDDYS LAB/
ABBOTT INDIA
 
P/E (TTM) x 29.6 56.1 52.7% View Chart
P/BV x 3.5 16.6 20.8% View Chart
Dividend Yield % 0.7 0.4 165.2%  

Financials

 DR. REDDYS LAB   ABBOTT INDIA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
ABBOTT INDIA
Mar-19
DR. REDDYS LAB/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,8758,834 32.5%   
Low Rs1,8885,458 34.6%   
Sales per share (Unadj.) Rs930.21,731.1 53.7%  
Earnings per share (Unadj.) Rs117.4211.9 55.4%  
Cash flow per share (Unadj.) Rs185.8219.9 84.5%  
Dividends per share (Unadj.) Rs20.0065.00 30.8%  
Dividend yield (eoy) %0.80.9 92.3%  
Book value per share (Unadj.) Rs844.4945.2 89.3%  
Shares outstanding (eoy) m166.0721.25 781.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.64.1 62.0%   
Avg P/E ratio x20.333.7 60.1%  
P/CF ratio (eoy) x12.832.5 39.5%  
Price / Book Value ratio x2.87.6 37.3%  
Dividend payout %17.030.7 55.5%   
Avg Mkt Cap Rs m395,496151,848 260.5%   
No. of employees `00022.03.5 630.3%   
Total wages/salary Rs m33,5624,356 770.5%   
Avg. sales/employee Rs Th7,032.810,555.5 66.6%   
Avg. wages/employee Rs Th1,527.91,249.9 122.2%   
Avg. net profit/employee Rs Th887.71,292.2 68.7%   
INCOME DATA
Net Sales Rs m154,48236,786 419.9%  
Other income Rs m3,3751,133 297.9%   
Total revenues Rs m157,85737,919 416.3%   
Gross profit Rs m31,7826,047 525.6%  
Depreciation Rs m11,348169 6,706.9%   
Interest Rs m88923 3,951.1%   
Profit before tax Rs m22,9206,989 328.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,8582,485 155.2%   
Profit after tax Rs m19,5004,503 433.0%  
Gross profit margin %20.616.4 125.1%  
Effective tax rate %16.835.6 47.3%   
Net profit margin %12.612.2 103.1%  
BALANCE SHEET DATA
Current assets Rs m111,10127,610 402.4%   
Current liabilities Rs m58,9738,569 688.2%   
Net working cap to sales %33.751.8 65.2%  
Current ratio x1.93.2 58.5%  
Inventory Days Days7960 131.8%  
Debtors Days Days9427 343.8%  
Net fixed assets Rs m101,2451,057 9,579.5%   
Share capital Rs m830213 390.6%   
"Free" reserves Rs m139,40619,873 701.5%   
Net worth Rs m140,23620,086 698.2%   
Long term debt Rs m22,0000-   
Total assets Rs m224,65629,409 763.9%  
Interest coverage x26.8311.6 8.6%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.71.3 55.0%   
Return on assets %9.115.4 59.0%  
Return on equity %13.922.4 62.0%  
Return on capital %14.934.9 42.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m88,673369 24,033.2%   
Fx outflow Rs m19,1044,918 388.4%   
Net fx Rs m69,569-4,549 -1,529.2%   
CASH FLOW
From Operations Rs m28,7044,991 575.1%  
From Investments Rs m-7,727-2,570 300.7%  
From Financial Activity Rs m-21,326-1,428 1,493.4%  
Net Cashflow Rs m-314993 -31.6%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 5.4 7.9 68.4%  
FIIs % 35.3 0.1 35,300.0%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 17.1 89.5%  
Shareholders   75,885 18,270 415.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   J.B.CHEMICALS  SUVEN LIFESCIENCES  STERLING BIOTECH  CADILA HEALTHCARE  ALEMBIC LTD  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

How to Trade this Market Crash(Podcast)

India's #1 trader, Vijay Bhambwani, decodes the crash...and reveals hidden opportunities one could profit from.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Feb 26, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade.

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

The Top 8 Trading Mistakes You Should Avoid(Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock(Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

This is What You Must Know as an Options Trader Today(Fast Profits Daily)

Feb 27, 2020

How you can stay on top of the challenges as an options trader.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Feb 28, 2020 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS